The Cannabinoid Receptor Agonist Win 55,212-2 Reduces the Initial Cerebral Damage After Hypoxic-Ischemic Injury in Fetal Lambs
Document Type
Article
Publication Date
11-29-2010
Abstract
The aim of the present work was to evaluate in an early time point the effect of the cannabinoid agonist WIN 55,212-2 after hypoxic–ischemic (HI) brain injury induced by partial occlusion of the umbilical cord of premature fetal lambs. Lambs were assigned to three experimental groups: one SHAM group: non-injured animals, and two hypoxic–ischemic groups that received a dose of 0.01 μg/kg WIN 55,212-2 (HI + WIN group) or not (HI +VEH) after 60 min of a hypoxic–ischemic event. All animals were managed on mechanical ventilation for 3 h and then sacrificed. Brains were perfusion-fixed and different regions separated for regional cerebral blood flow measurement, apoptosis quantification by TUNEL method and S-100 protein analysis by flow cytometry. The number of apoptotic cells was lower in the HI + WIN group in all regions studied. Moreover, animals treated with the cannabinoid agonist showed higher values in the percentage of S-100 positive cells in all regions, except in the cortex. In both studies we obtained similar values between SHAM group and HI + WIN group. Our results suggest that the administration of the cannabinoid agonist WIN 55,212-2 after hypoxic–ischemic brain injury in preterm lambs decreases brain injury reducing the delayed cell death and glial damage.
Repository Citation
Alonso-Alconada, D.,
Alvarez, F. J.,
Alvarez, A.,
Mielgo, V. E.,
Goñi-de-Cerio, F.,
Rey-Santano, C.,
Caballero, A.,
Martinez-Orgado, J.,
& Hilario, E.
(2010). The Cannabinoid Receptor Agonist Win 55,212-2 Reduces the Initial Cerebral Damage After Hypoxic-Ischemic Injury in Fetal Lambs. Brain Research, 1362, 150-159.
https://corescholar.libraries.wright.edu/ncbp/541
DOI
10.1016/j.brainres.2010.09.050
